Tevogen Bio Holdings Inc. financial data

Symbol
TVGN, TVGNW on Nasdaq
Location
Warren, NJ
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 30% % 238%
Debt-to-equity -151% % -32%
Return On Equity 392% % 1311%
Return On Assets -762% % -296%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 198,689,921 shares
Common Stock, Shares, Outstanding 197,391,411 shares 16%
Entity Public Float $21,400,000 USD -16%
Common Stock, Value, Issued $19,740 USD 16%
Weighted Average Number of Shares Outstanding, Basic 196,028,784 shares 15%
Weighted Average Number of Shares Outstanding, Diluted 196,028,784 shares 15%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense $11,842,117 USD -59%
General and Administrative Expense $19,051,407 USD 11%
Operating Income (Loss) $30,893,524 USD 33%
Net Income (Loss) Attributable to Parent $31,042,404 USD -292%
Earnings Per Share, Basic 0 USD/shares 89%
Earnings Per Share, Diluted 0 USD/shares 0%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $0 USD
Assets, Current $2,121,734 USD -40%
Property, Plant and Equipment, Net $163,930 USD -51%
Operating Lease, Right-of-Use Asset $1,451,198 USD 398%
Other Assets, Noncurrent $565,884 USD 325%
Assets $4,493,669 USD 4.8%
Accounts Payable, Current $3,311,931 USD -43%
Accrued Liabilities, Current $1,196,644 USD -15%
Liabilities, Current $6,737,315 USD -35%
Operating Lease, Liability, Noncurrent $1,150,476 USD 2603%
Liabilities $12,317,565 USD 18%
Retained Earnings (Accumulated Deficit) $134,982,969 USD -30%
Stockholders' Equity Attributable to Parent $7,823,896 USD -26%
Liabilities and Equity $4,493,669 USD 4.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,308,063 USD -53%
Net Cash Provided by (Used in) Financing Activities $4,000,000 USD 65%
Common Stock, Shares Authorized 800,000,000 shares 0%
Common Stock, Shares, Issued 197,391,411 shares 16%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $691,937 USD 161%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,037,094 USD -56%
Deferred Tax Assets, Valuation Allowance $16,551,169 USD 123%
Deferred Tax Assets, Gross $16,610,885 USD 120%
Operating Lease, Liability $234,859 USD
Depreciation $40,553 USD 0%
Lessee, Operating Lease, Liability, to be Paid $244,446 USD
Property, Plant and Equipment, Gross $721,769 USD 0%
Operating Lease, Liability, Current $327,740 USD 27%
Lessee, Operating Lease, Liability, to be Paid, Year Two $13,975 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $230,471 USD
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,587 USD
Deferred Tax Assets, Operating Loss Carryforwards $6,808,826 USD 81%
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Additional Paid in Capital $118,339,343 USD 30%
Deferred Tax Assets, Net of Valuation Allowance $59,716 USD -51%
Share-based Payment Arrangement, Expense $20,737,967 USD -2.5%
Interest Expense $24,571 USD -84%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%